12/2 Yahoo! Finance: PFE News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Yahoo! Finance: PFE News - Latest Financial News for PFIZER INC IBD's Top 10 - Tuesday (Investor's Business Daily) December 1, 2009 at 7:24 pm Stocks Climb In Mixed Volume Pops & Drops: Pfizer, Human Genome... (at CNBC) December 1, 2009 at 6:02 pm Business Highlights (AP) December 1, 2009 at 5:56 pm The economic recovery seems on track for slow but steady gains after new reports Tuesday showed growth in manufacturing activity, construction spending and contracts to buy homes. [video] Stock Pops & Drops (at CNBC) December 1, 2009 at 5:48 pm Movers roundup: Bed Bath & Beyond (AP) December 1, 2009 at 5:18 pm Shares of Bed Bath & Beyond rose after an analyst added the housewares retailer to its best ideas list and reiterated an "Outperform" rating. Pfizer CEO opposes any US reform targeting prices (at Reuters) December 1, 2009 at 5:11 pm Pfizer inks deal for new drugmaking technology (AP) December 1, 2009 at 4:34 pm Pfizer Inc. will spend up to $115 million for rights to an Israeli biotech company's experimental drug and its promising technology for making that drug and others in carrot cells. Pfizer, Staples, OmniVision, Guess are big movers (AP) December 1, 2009 at 4:27 pm The following stocks were among those that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market: Bonds: Out. Stocks: Out. What's Left? (at Motley Fool) December 1, 2009 at 4:06 pm Pfizer CEO repeats health law support (at bizjournals.com) December 1, 2009 at 4:05 pm Pfizer CEO declines to comment on dividend (at MarketWatch) December 1, 2009 at 3:47 pm Pfizer CEO says he supports Senate healthcare bill (at MarketWatch) December 1, 2009 at 3:41 pm The Most Overlooked Investment Opportunity (at Motley Fool) December 1, 2009 at 3:32 pm Pfizer Takes In an Orphan on the Cheap (at Motley Fool) December 1, 2009 at 3:13 pm Pfizer CEO voices support for Mass. (at bizjournals.com) December 1, 2009 at 3:05 pm UPDATE - Pfizer acquires rights to Protalix's Gaucher drug (at Reuters) December 1, 2009 at 2:52 pm [video] Stock Tips For A Rough 2010 [3.2 min] (at MarketWatch) December 1, 2009 at 2:45 pm Patrick Morris of Hagin Investment Management offers ideas for what stocks would be good to include in a portfolio in 2010, which he says may be challenging for stock investors. Abbott Makes All the Right Moves (at Motley Fool) December 1, 2009 at 2:32 pm Merck Makes a Mark on Good Cholesterol (at Motley Fool) December 1, 2009 at 2:27 pm Protalix shares fall following Pfizer deal (AP) December 1, 2009 at 2:07 pm Shares of Protalix BioTherapeutics Inc. fell Tuesday as a newly announced licensing deal with Pfizer Inc. appeared to dispel hopes of a buyout. Of Pfizer, a New Treatment for a Rare Disease and Carrot Cells (at The Wall Street Journal Online) December 1, 2009 at 2:05 pm Pfizer signs development deal with Protalix (AP) December 1, 2009 at 1:11 pm Pfizer will spend up to $115 million for rights to an Israeli biotech company's experimental drug and its promising technology for making that drug and others in carrot cells. Stocks Rise as Dubai Fears Ebb (at The Wall Street Journal Online) December 1, 2009 at 12:59 pm Better Buy: Pfizer or Teva Pharmaceutical? (at Motley Fool) December 1, 2009 at 12:54 pm Pfizer Chomps On A Carrot (at CNBC) December 1, 2009 at 12:12 pm Swiss fine drug firms $5.7M for price-fixing (AP) December 1, 2009 at 10:59 am The Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of 5.7 million francs by competition regulators on Tuesday for alleged price fixing of drugs for erectile dysfunction. [video] Stocks Point to Bullish Month (at TheStreet.com) December 1, 2009 at 10:53 am Pfizer Higher on Protalix Deal (at Barrons.com) December 1, 2009 at 10:23 am Protalix-Pfizer Tag Team Against Genzyme: BioBuzz (at TheStreet.com) December 1, 2009 at 10:09 am Analyst Note: Goldman cautious on Abbott, Lilly (AP) December 1, 2009 at 10:09 am A Goldman Sachs analyst reaffirmed her outlook for Abbott Laboratories and Eli Lilly & Co., but expressed more caution on her respective ratings, citing a mix of drug sales and operating performances in the coming year. 5-Star Stocks Poised to Pop: Abbott Labs (at Motley Fool) December 1, 2009 at 9:30 am Genzyme resumes shipping from Allston plant (at MarketWatch) December 1, 2009 at 9:29 am Pfizer Buys Rights To Protalix Drug for As Much as $115 Million (at Fox Business) December 1, 2009 at 9:07 am Before the Bell: Staples, Barrick Gold, Pfizer in view (at MarketWatch) December 1, 2009 at 8:43 am [$$] Pfizer to Pay Protalix Up to $115 Million in Gaucher's Deal (at The Wall Street Journal Online) December 1, 2009 at 8:14 am Pfizer Acquires Rights to Treatment for Rare Disorder (at The New York Times) December 1, 2009 at 7:46 am UPDATE - Pfizer acquires rights to Protalix's Gaucher drug (at Reuters) December 1, 2009 at 7:18 am Pfizer signs development deal with Protalix (AP) December 1, 2009 at 6:56 am Drug developer Pfizer Inc. is paying Protalix BioTherapeutics Inc. $60 million upfront for licensing rights to a developing Gaucher's disease treatment, the companies said on Tuesday. Pfizer, Protalix agree deal on taliglucerase (at MarketWatch) December 1, 2009 at 6:39 am Swiss fine drug firms $5.7M for price-fixing (AP) December 1, 2009 at 6:33 am The Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of 5.7 million francs by competition regulators on Tuesday for alleged price fixing of drugs for erectile dysfunction. Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment (Business Wire) December 1, 2009 at 6:30 am NEW YORK----Pfizer and Protalix today announced that they have entered into an agreement to develop and commercialize taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase in development for the potential treatment of Gaucher’s disease. Pfizer, Berkshire Hathaway: Ratings Changes (at TheStreet.com) December 1, 2009 at 5:00 am Wal-Mart Rivals Safety of U.S. Government (TheStreet.com) December 1, 2009 at 5:00 am AmericaÂ's biggest retailer is the ultimate safe haven, even though it doesnÂ't carry Standard & PoorÂ's highest credit rating. Wal-Mart Rivals Safety of U.S. Government (TheStreet.com) December 1, 2009 at 5:00 am UPDATE - Pfizer to launch generic drugs in Japan (at Reuters) December 1, 2009 at 2:40 am UPDATE - India's Cipla in generic supply talks with Pfizer (at Reuters) December 1, 2009 at 1:50 am Pfizer says to start selling generic drugs in Japan (at Reuters) December 1, 2009 at 1:02 am   This email was sent to gatdemit001@gmail.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.